INDAPTUS THERAPEUTICS INC
INDP·45339J204·US·Common Stock·Healthcare - Biotechnology-Activist
INDP (INDAPTUS THERAPEUTICS INC) is held by 3 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($71,013), GEODE CAPITAL MANAGEMENT, LLC ($49,152), MORGAN STANLEY ($4,909). Net institutional sentiment: Mixed.
3
Holders
Avg rating(1 Elite)
$125,074
Total Value
60% (5)
Fund Consensus
3 buying - 2 selling
Who's Trading
ActivistDJDai Junyi8.4%Jun 26, 2026
ActivistSLSino Lion Ventures Ltd29.2%Jun 26, 2026
ActivistYTYang Ting8.4%Jun 26, 2026
ActivistYYYao Yun31.5%Jun 26, 2026
ActivistYYYao Yun37.1%Apr 29, 2026
ActivistYIYA II PN, Ltd.0.0%Apr 6, 2026
ActivistLDLazar David E.47.9%Mar 24, 2026
ActivistJAJeffery A. Meckler12.7%Dec 30, 2025
ActivistNMNewman Michael James5.4%Dec 30, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer